Learn more

GOVERNMENT OF THE U S A AS REP

Overview
  • Total Patents
    24
About

GOVERNMENT OF THE U S A AS REP has a total of 24 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are HAYNES BARTON F, CT NAC DE SANIDAD AGROPECUARIA and CELLERANT THERAPEUTICS INC.

Patent filings in countries

World map showing GOVERNMENT OF THE U S A AS REPs patent filings in countries

Patent filings per year

Chart showing GOVERNMENT OF THE U S A AS REPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lai Ching-Juh 2
#2 Qasba Pradman K 2
#3 Goncalvez Ana P 2
#4 Purcell Robert H 2
#5 Zhao Ming Lang 1
#6 Parent Mark G 1
#7 Pastan Ira 1
#8 Keller Erich James 1
#9 Michienzi Christine Marie 1
#10 Isle Brian J 1

Latest patents

Publication Filing date Title
WO2010129959A1 Compositions and methods for the prevention and treatment of lupus nephritis using anti-dsdna germline antibodies
WO2010099322A1 Francisella tularensis variants: compositions and methods of use
WO2010093924A1 Serological screening for hhv-8 infection using antigen mixtures
WO2010056820A1 Wavelength-scaled ultra-wideband antenna array
WO2010059418A1 Substituted triazine and purine compounds, methods of inhibiting cruzain and rhodesain and methods of treating chagas disease and african trypanosomiasis
WO2010045654A1 Curved radiation detector fabrication methods and systems
WO2010042582A1 Hybrid preconcentrator for detection of materials
US2010055078A1 Methods of making a transplantable bone repair system using multipotent stem cells
WO2010014248A2 Antiviral activity of the protein scytovirin and methods of use
WO2009126898A2 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus( (jev) and their use
WO2009102820A2 Modified sugar substrates and methods of use
WO2010065044A1 Blocking mesothelin peptide fragments
WO2009058766A2 Methods of regulating the expression of mir-34a and p18ink4c
WO2009131563A1 Insensitive gun propellant, ammunition round assembly, armament system, and related methods
WO2009026183A1 Use of chimeric hiv/siv gag proteins to optimize vaccine-induced t cell responses against hiv gag
US2009081212A1 Use and targeting of cd98 light-chain proteins in therapies for thyroid hormone disorders
US2008311613A1 Artificial skin surface film liquids
WO2008124646A2 Use of amyloid proteins as vaccine scaffolds
EP2144931A2 Monoclonal antibodies against dengue and other viruses with deletion in fc region
WO2009025646A1 Alpha 1-3 n-galactosyltransferase with altered donor specificities